Literature DB >> 16129568

Cerebral blood flow velocity and erythrocyte deformability in heavy alcohol drinkers at the acute stage and two weeks after withdrawal.

Zuzana Gdovinová1.   

Abstract

OBJECTIVE: The aim of the study was to measure changes in blood flow velocity (V(mean)) and erythrocyte deformability (ED) in heavy alcohol drinkers after withdrawal and the relationship between them.
METHODS: The subjects were 32 heavy alcohol drinkers, mean age 47 years (22 men and 10 women). V(mean) was determined by a transcranial 2 MHz pulsed Doppler probe. ED was estimated by the method of cation-osmotic haemolysis (COH). The results were compared with those for 20 healthy volunteers.
RESULTS: The study revealed a significant decrease in V(mean) and ED after admission. V(mean) in the left middle cerebral artery (MCA) was 45.1+/-10.2 cm/s as compared with 59.1+/-7.5 cm/s in controls; in the right MCA, it was 46.8+/-11.3 cm/s as compared with 59.0+/-7.6 cm/s in controls (p < 0.001 in each case). But while V(mean) was significantly increased after 14 days withdrawal (54.4+/-10.4 cm/s in the left MCA, p < 0.001, and 54.3+/-12.1 cm/s in the right MCA, p < 0.01), ED showed only small change. A significant difference between V(mean) in men and women was found.
CONCLUSION: The changes in V(mean) after withdrawal are more influenced by plasma composition than by changes in ED.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16129568     DOI: 10.1016/j.drugalcdep.2005.07.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  1 in total

1.  Variability of physiological brain perfusion in healthy subjects - A systematic review of modifiers. Considerations for multi-center ASL studies.

Authors:  Patricia Clement; Henk-Jan Mutsaerts; Lena Václavů; Eidrees Ghariq; Francesca B Pizzini; Marion Smits; Marjan Acou; Jorge Jovicich; Ritva Vanninen; Mervi Kononen; Roland Wiest; Egill Rostrup; António J Bastos-Leite; Elna-Marie Larsson; Eric Achten
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-10       Impact factor: 6.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.